Cascade Prodrug Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $450K

  • Investors
  • 14

Cascade Prodrug General Information

Description

Developer of chemotherapy technology designed to treat a variety of solid tumor indications. The company's technology specializes in the advantage of tumor hypoxia and triggers drug conversion in the tumor where it's needed, thus limiting the exposure of healthy tissue to a potent cytotoxic agent, enabling cancer patients to experience an improved safety profile relative to currently approved chemotherapy agents.

Contact Information

Website
www.cascadeprodrug.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Post Office Box 13020
  • Eugene, OR 97440
  • United States
+1 (541)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Post Office Box 13020
  • Eugene, OR 97440
  • United States
+1 (541)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cascade Prodrug Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 06-Apr-2020 $450K Completed Generating Revenue
6. Later Stage VC 03-Jun-2016 Completed Generating Revenue
5. Later Stage VC 03-Apr-2015 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Apr-2013 Completed Generating Revenue
3. Grant 11-May-2012 Completed Generating Revenue
2. Early Stage VC 14-Feb-2012 $400K $400K Completed Generating Revenue
1. Grant 29-Oct-2010 $244K Completed Generating Revenue
To view Cascade Prodrug’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cascade Prodrug Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Cascade Prodrug Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4267136-A1 Combination therapy with a vinca alkaloid n-oxide and an immune checkpoint inhibitor Pending 23-Dec-2020
US-20240139175-A1 Combination therapy with a vinca alkaloid n-oxide and an immune checkpoint inhibitor Pending 23-Dec-2020
EP-4267136-A4 Combination therapy with a vinca alkaloid n-oxide and an immune checkpoint inhibitor Pending 23-Dec-2020
US-20100016252-A1 Mannich base n-oxide drugs Active 19-Mar-2007
US-8410075-B2 Mannich base n-oxide drugs Active 19-Mar-2007 C07C291/04
To view Cascade Prodrug’s complete patent history, request access »

Cascade Prodrug Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cascade Prodrug Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Elevate Capital Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Cascade Prodrug FAQs

  • When was Cascade Prodrug founded?

    Cascade Prodrug was founded in 2009.

  • Where is Cascade Prodrug headquartered?

    Cascade Prodrug is headquartered in Eugene, OR.

  • What is the size of Cascade Prodrug?

    Cascade Prodrug has 4 total employees.

  • What industry is Cascade Prodrug in?

    Cascade Prodrug’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Cascade Prodrug a private or public company?

    Cascade Prodrug is a Private company.

  • What is Cascade Prodrug’s current revenue?

    The current revenue for Cascade Prodrug is .

  • How much funding has Cascade Prodrug raised over time?

    Cascade Prodrug has raised $2.57M.

  • Who are Cascade Prodrug’s investors?

    Elevate Capital, , , , and are 5 of 14 investors who have invested in Cascade Prodrug.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »